Halliburton Company (HAL) surpassed market estimates on both revenue and earnings for the fourth quarter of 2018 but shares fell over 1% during premarket hours on Tuesday. Total company revenue of $5.94 billion stayed relatively unchanged from the same period last year.
Net income attributable to the company was $664 million or $0.76 per share. This compares to a net loss of $824 million or $0.94 per share in the prior-year period. Adjusted income from continuing operations was $358 million or $0.41 per share.
Jeff Miller, Chairman, President and CEO said, “As North American oil production reaches historic highs, operators focus on returns over growth, and the international recovery continues, Halliburton is well prepared to thrive. We intend to dynamically respond to the changing market environment, reduce capital spending, develop differentiating technologies, and generate strong cash flow.”
Also see: Halliburton Q4 2018 Earnings Conference Call Transcript
During the quarter, revenues in the Completion and Production segment and the Drilling and Evaluation segment did not see much change compared to the prior-year period. On a sequential basis, revenues in Completion and Production fell 8% mainly due to lower activity and pricing for stimulation services in North America.
Drilling and Evaluation revenue grew 5% sequentially mainly due to year-end software sales, increased fluids activity in the Gulf of Mexico and improved project management activity in Latin America.
Earnings Preview: Slide in crude oil prices could hurt Halliburton in Q4
On a year-over-year basis, Halliburton posted revenues declines across most regions except for Middle East/Asia which delivered revenue growth of 8%. On a sequential basis, revenue in North America dropped 11% due to lower activity and pricing in stimulation services. International revenue improved 7% sequentially helped by higher product and software sales in the Middle East/Asia and Latin America regions.
During the quarter, Halliburton acquired SmartFibres, a producer of fiber optic pressure gauges, and also signed two contracts with Eni Iraq BV to drill development wells over the next two years.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on